Ellis Investment Partners LLC Boosts Stock Position in UnitedHealth Group Incorporated $UNH

Ellis Investment Partners LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.3% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,555 shares of the healthcare conglomerate’s stock after acquiring an additional 243 shares during the period. Ellis Investment Partners LLC’s holdings in UnitedHealth Group were worth $1,109,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the business. Vanguard Group Inc. raised its stake in shares of UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after buying an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after buying an additional 2,486,839 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of UnitedHealth Group by 2.5% during the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock worth $4,257,131,000 after buying an additional 196,696 shares in the last quarter. Nuveen LLC purchased a new position in shares of UnitedHealth Group during the 1st quarter worth approximately $3,846,764,000. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of UnitedHealth Group by 13.6% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after buying an additional 847,054 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $354.30 on Monday. The business’s fifty day moving average price is $318.21 and its two-hundred day moving average price is $348.08. The stock has a market cap of $320.88 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 2.29 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the business earned $6.80 EPS. UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

Analyst Ratings Changes

UNH has been the topic of a number of research reports. KeyCorp upped their price target on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Bank of America upped their price target on UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Wednesday, October 8th. Oppenheimer lowered their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Cantor Fitzgerald restated an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, JPMorgan Chase & Co. upped their price target on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $383.09.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.